Rare diseases
Investigational molecules
Locations
Back to France3 418 clinical trials in Clichy, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
FranceStudy of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma
FranceStudy of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma
FranceStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
FranceStudy of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
FranceFranceStudy on the Safety and Effectiveness of MK-1200 for Patients with Advanced Solid Tumors
FranceStudy on TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for or Refusing Platinum-Based Chemotherapy
FranceStudy on L19TNF and Doxorubicin for Patients with Advanced or Metastatic Soft Tissue Sarcoma
FranceStudy of Zolbetuximab Alone and with Drug Combination for Patients with Advanced Stomach or Gastroesophageal Junction Cancer
FranceStudy on the Effectiveness and Safety of Perampanel for Children with Epilepsy
FranceStudy of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on inflammatory bowel diseases and advanced treatment methods, including studies on Crohn's disease and ulcerative colitis using fecal microbiota transplantation as therapeutic approaches.
Research aims to improve patient outcomes through novel therapeutic interventions and treatment strategies.
Comprehensive studies on liver diseases and biliary tract conditions, investigating new treatments for cirrhosis, portal hypertension, and various forms of liver cancer.
Advanced therapeutic approaches combining immunotherapy and targeted treatments.
Groundbreaking research on pancreatic cancer and metabolic conditions, evaluating novel drug combinations and treatment protocols.
Focus on improving survival rates and treatment efficacy in advanced-stage diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
